Brought to you by:
Powered by wagescape.com
Labor Market Pulse
NC NONMETROPOLITAN AREA Edition
Focus: LIFE SCI
Nonmetro NC biomanufacturing boom outpaces its talent pipeline.
3.5%
NC unemployment rate
vs 4.1% national, down 0.4pt year-over-year
$111,259
Regulatory Affairs pay
Metro median, up significantly vs stable $104K national
$3B
New biomanufacturing investment
Amgen Holly Springs + J&J Wilson County, ~790 jobs
-70,000
NC labor force change
Year-over-year contraction statewide
This Month's Takeaways
Biomanufacturing jobs are arriving faster than specialized talent can follow.
Amgen's Holly Springs and J&J's Wilson County projects add nearly 800 jobs and $3B in capital, but BioWork-style credential programs address operators, not the regulatory, quality, and CMC talent these facilities ultimately need. Expect sustained premiums for experienced hires willing to relocate into nonmetro sites.
Entry-level manufacturing pay now competes directly with four-year degree paths.
A $67,000 starting salary for a 19-year-old BioWork graduate at J&J reframes local wage expectations for technician and operator roles well above the metro's $47,794 lab technician median. Organizations benchmarking entry-level manufacturing comp against lab tech data may be understating what's required to compete for this pipeline.
Regulatory Affairs pay climbed while the national market held flat.
Metro Regulatory Affairs Specialist pay rose to a $111,259 median, a significant increase, while the national median sat stable near $104,000. Divergence this sharp in a nonmetro labor market suggests local employers are bidding specifically for scarce regulatory talent tied to the biomanufacturing buildout rather than following broader wage trends.
CDMO consolidation may expand the outsourcing bench, not just shrink it.
Kincellis Advanced Therapies' leadership hire from Resilience/Lyell/Pfizer signals cell therapy CDMO capacity consolidating around fewer, more capable providers. For build-vs-outsource decisions, this could mean fewer but deeper-capability partners available to absorb specialized workload that nonmetro sites can't staff internally.
Local Labor Conditions
Rural North Carolina's nonmetro counties remain tethered to statewide dynamics — 3.5% state unemployment and a labor force that contracted by roughly 70,000 people over the year — but biomanufacturing capital is landing disproportionately in micropolitan and nonmetro corridors, with Amgen's $1B Holly Springs expansion and J&J's $2B Wilson County biologics campus both situated outside core metro boundaries. Population outmigration and declining labor force participation in nonmetro counties collide directly with employers trying to staff large-scale manufacturing builds, tightening the pool for both operators and the specialized scientific oversight those facilities require.
Leadership & Talent Implications
Nonmetro life sciences employers face a structural mismatch: entry-level manufacturing roles can be filled through credential pipelines like Wilson Community College's BioWork program, but specialized scientific, quality, and regulatory talent must largely be recruited from outside the immediate labor shed, often from Raleigh-Durham's tighter 3.1% unemployment market. This pushes build-vs-outsource calculus toward hybrid models — local operator workforces paired with centralized or outsourced regulatory and quality functions — rather than assuming a single site can be fully self-sufficient on specialized headcount. Consider evaluating whether current site-level compensation structures account for the premium required to relocate or retain regulatory and quality leadership into nonmetro locations rather than benchmarking solely against metro rates.
